Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yang Si

Showing results (261-270 of 284) with videos related to

Pageof 29
Sort By:
Annals of Medicine|January 21, 2025
Chemoimmunotherapy as induction treatment in concurrent chemoradiotherapy for patients with nasopharyngeal carcinoma stage IVaKun-Peng Wu, Qing-Qing Li, Xu-Qiang Luo, et al.
Small (Weinheim an Der Bergstrasse, Germany)|October 20, 2023
Operando Spectroscopy Observation of Mo Clusters-Ti<sub>3</sub> C<sub>2</sub> T<sub>X</sub> Catalyst/Support Interface's Dynamic Evolution in Hydrogen Evolution ReactionPeng Fei Wu, Yu Qi Yang, Hong Yan Xi, et al.
BMC Medicine|June 1, 2022
Subsequent treatments beyond progression on osimertinib in EGFR-mutated NSCLC and leptomeningeal metastasesMei-Mei Zheng, Yang-Si Li, Hai-Yan Tu, et al.
Epilepsia|November 24, 2021
Simulated driving in the epilepsy monitoring unit: Effects of seizure type, consciousness, and motor impairmentAvisha Kumar, Reese Martin, William Chen, et al.
The New Phytologist|December 23, 2025
Leaf economic traits link drought and heat tolerance of woody species in two contrasting hydrothermal habitatsYang-Si-Ding Wang, Jiao-Lin Zhang, Ya-Jun Chen, et al.
Oncotarget|April 17, 2017
Reduced NOV expression correlates with disease progression in colorectal cancer and is associated with survival, invasion and chemoresistance of cancer cellsJun Li, Lin Ye, Ping-Hui Sun, et al.
Lung Cancer (Amsterdam, Netherlands)|April 28, 2019
A molecular graded prognostic assessment (molGPA) model specific for estimating survival in lung cancer patients with leptomeningeal metastasesKai Yin, Yang-Si Li, Mei-Mei Zheng, et al.
Clinical Lung Cancer|December 25, 2024
PEARL: A Multicenter Phase 2 Study of Lorlatinib in Patients with ALK-Rearranged NSCLC and Central Nervous System DiseaseChang Lu, Hong-Hong Yan, Chan-Yuan Zhang, et al.
European Journal of Cancer (Oxford, England : 1990)|April 21, 2021
Clinical outcomes of non-small cell lung cancer patients with leptomeningeal metastases after immune checkpoint inhibitor treatmentsMei-Mei Zheng, Hai-Yan Tu, Jin-Ji Yang, et al.
JTO Clinical and Research Reports|September 16, 2024
Combination of Cytologic Findings and Circulating Tumor DNA From Cerebrospinal Fluid Revealed SCLC Transformation in Patients With Leptomeningeal Metastases of Lung AdenocarcinomaJia-Xin Lin, Kai Yin, Li-Xu Yan, et al.
Pageof 29

Showing results (261-270 of 284) with videos related to

Sort By:
Pageof 29
Annals of Medicine|January 21, 2025
Chemoimmunotherapy as induction treatment in concurrent chemoradiotherapy for patients with nasopharyngeal carcinoma stage IVaKun-Peng Wu, Qing-Qing Li, Xu-Qiang Luo, et al.
Small (Weinheim an Der Bergstrasse, Germany)|October 20, 2023
Operando Spectroscopy Observation of Mo Clusters-Ti<sub>3</sub> C<sub>2</sub> T<sub>X</sub> Catalyst/Support Interface's Dynamic Evolution in Hydrogen Evolution ReactionPeng Fei Wu, Yu Qi Yang, Hong Yan Xi, et al.
BMC Medicine|June 1, 2022
Subsequent treatments beyond progression on osimertinib in EGFR-mutated NSCLC and leptomeningeal metastasesMei-Mei Zheng, Yang-Si Li, Hai-Yan Tu, et al.
Epilepsia|November 24, 2021
Simulated driving in the epilepsy monitoring unit: Effects of seizure type, consciousness, and motor impairmentAvisha Kumar, Reese Martin, William Chen, et al.
The New Phytologist|December 23, 2025
Leaf economic traits link drought and heat tolerance of woody species in two contrasting hydrothermal habitatsYang-Si-Ding Wang, Jiao-Lin Zhang, Ya-Jun Chen, et al.
Oncotarget|April 17, 2017
Reduced NOV expression correlates with disease progression in colorectal cancer and is associated with survival, invasion and chemoresistance of cancer cellsJun Li, Lin Ye, Ping-Hui Sun, et al.
Lung Cancer (Amsterdam, Netherlands)|April 28, 2019
A molecular graded prognostic assessment (molGPA) model specific for estimating survival in lung cancer patients with leptomeningeal metastasesKai Yin, Yang-Si Li, Mei-Mei Zheng, et al.
Clinical Lung Cancer|December 25, 2024
PEARL: A Multicenter Phase 2 Study of Lorlatinib in Patients with ALK-Rearranged NSCLC and Central Nervous System DiseaseChang Lu, Hong-Hong Yan, Chan-Yuan Zhang, et al.
European Journal of Cancer (Oxford, England : 1990)|April 21, 2021
Clinical outcomes of non-small cell lung cancer patients with leptomeningeal metastases after immune checkpoint inhibitor treatmentsMei-Mei Zheng, Hai-Yan Tu, Jin-Ji Yang, et al.
JTO Clinical and Research Reports|September 16, 2024
Combination of Cytologic Findings and Circulating Tumor DNA From Cerebrospinal Fluid Revealed SCLC Transformation in Patients With Leptomeningeal Metastases of Lung AdenocarcinomaJia-Xin Lin, Kai Yin, Li-Xu Yan, et al.
Pageof 29